Phillip Devlin, MD, FACR
Chief, Division of Brachytherapy
Associate Professor of Radiation Oncology, Harvard Medical School
Image
Phillip Devlin, MD, FACR
Chief, Division of Brachytherapy
Associate Professor of Radiation Oncology, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
University of Virginia School of Medicine
1991
Charlottesville
VA
Internship
General Surgery
Georgetown University Hospital
Washington
DC
Residency
Surgery
Georgetown University Hospital
Washington
DC
Residency
Radiation Oncology
University of Pennsylvania School of Medicine
1995
Philadelphia
PA
Fellowship
Brachytherapy
Memorial Sloan Kettering Cancer Center
1996
New York
NY
Certifications
American Board of Radiology (Radiation Oncology)
Professional History
Phillip Devlin, MD, FACR is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. He earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996. Dr. Devlin joined the staff of Dana-Farber in 1997.In addition to lecturing extensively both nationally and internationally, Dr. Devlin established and directs the Harvard Medical School Annual Brachytherapy Review Course, has more than 50 published manuscripts and book chapters and is editor of the Lippincott, Williams and Wilkins’ text, Brachytherapy: Applications and Techniques. Dr. Devlin is currently on the Executive Committees of both the American Society for Radiation Oncology (ASTRO) and the Massachusetts Radiological Society. In 2008 he was named a Fellow of the American College of Radiology (FACR), and he is currently leading two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project.
Publications
Refractory cutaneous Langerhans cell histiocytosis of the vulva treated with high-dose-rate surface applicator brachytherapy. View Abstract
Skin marker for MR-only surface high-dose-rate brachytherapy. View Abstract
RapidBrachyIVBT: A dosimetry software for patient-specific intravascular brachytherapy dose calculations on optical coherence tomography images. View Abstract
Feasibility and clinical implementation of MRI-guided surface brachytherapy. View Abstract
Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides. View Abstract
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases. View Abstract
Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma. View Abstract
Brachytherapy as Salvage Treatment for Meningioma With Malignant Progression After Exhausting Other Treatment Options: 2-Dimensional Operative Video. View Abstract
ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy. View Abstract
Salvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysis. View Abstract
The Essential Anthony. View Abstract
Feasibility of magnetic resonance-only high-dose-rate surface brachytherapy for clinical application. View Abstract
Acute and late complications and toxicities of skin brachytherapy. View Abstract
Selection criteria for high-dose-rate surface brachytherapy and electron beam therapy in cutaneous oncology. View Abstract
Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face. View Abstract
ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies. View Abstract
Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy. View Abstract
Recalcitrant extramammary Paget's disease treated successfully with high-dose-rate brachytherapy: A case series and review of the literature. View Abstract
Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT. View Abstract
Multilingual Analysis of the Quality and Readability of Online Health Information on the Adverse Effects of Breast Cancer Treatments. View Abstract
Management of primary skin cancer during a pandemic: Multidisciplinary recommendations. View Abstract
Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: A single-center case series and national database comparison. View Abstract
Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand. View Abstract
In Reply to the American Academy of Dermatology Letter Regarding: Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: An American Society for Radiation Oncology Clinical Practice Guideline. View Abstract
Development and clinical implementation of semi-automated treatment planning including 3D printable applicator holders in complex skin brachytherapy. View Abstract
Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. View Abstract
Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. View Abstract
Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. View Abstract
Modern Brachytherapy. View Abstract
Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis. View Abstract
A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer. View Abstract
High-throughput sequencing of the T cell receptor ß gene identifies aggressive early-stage mycosis fungoides. View Abstract
Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer. View Abstract
American College of Radiology-American Brachytherapy Society practice parameter for electronically generated low-energy radiation sources. View Abstract
Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy. View Abstract
Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer. View Abstract
Dose comparison between TG-43-based calculations and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions. View Abstract
Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis. View Abstract
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis. View Abstract
Novel Application of High-Dose-Rate Brachytherapy for Severe, Recalcitrant Acrodermatitis Continua of Hallopeau. View Abstract
The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy. View Abstract
High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis. View Abstract
Skin surface brachytherapy: A survey of contemporary practice patterns. View Abstract
Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience. View Abstract
Clinical implementation of a novel applicator in high-dose-rate brachytherapy treatment of esophageal cancer. View Abstract
Successful use of brachytherapy for a severe hidradenitis suppurativa variant. View Abstract
WE-DE-201-11: Sensitivity and Specificity of Verification Methods Based On Total Reference Air Kerma (TRAK) Or On User Provided Dose Points for Graphically Planned Skin HDR Brachytherapy. View Abstract
SU-G-201-04: Can the Dynamic Library of Flap Applicators Replace Treatment Planning in Surface Brachytherapy? View Abstract
Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis. View Abstract
Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy. View Abstract
American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer. View Abstract
Brachytherapy in the treatment of recurrent aggressive falcine meningiomas. View Abstract
SU-E-T-783: Using Matrixx to Determine Transit Dose Contribution Over Clinically Useful Limits of HDR Source Activity. View Abstract
SU-E-T-413: Examining Acquisition Rate for Using MatriXX Ion Chamber Array to Measure HDR Brachytherapy Treatments. View Abstract
SU-E-T-301: Dosimetric Comparison Between Adaptive and Rectilinear Template-Based Prostate Seed Implants. View Abstract
SU-E-T-165: Characterization of Dose Distributions in High-Dose-Rate Surface Brachytherapy. View Abstract
Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer. View Abstract
High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. View Abstract
Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. View Abstract
Independent brachytherapy plan verification software: improving efficacy and efficiency. View Abstract
Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series. View Abstract
WE-A-17A-03: Catheter Digitization in High-Dose-Rate Brachytherapy with the Assistance of An Electromagnetic (EM) Tracking System. View Abstract
SU-E-T-362: Automatic Catheter Reconstruction of Flap Applicators in HDR Surface Brachytherapy. View Abstract
Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results. View Abstract
PSA screening: the case in favor. View Abstract
Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. View Abstract
Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy. View Abstract
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. View Abstract
American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy. View Abstract
Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. View Abstract
Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. View Abstract
Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancer. View Abstract
Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. View Abstract
High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. View Abstract
Variability in prostate volume as determined by MRI versus ultrasound and its impact on treatment recommendations for patients with favorable-risk prostate cancer. View Abstract
Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity. View Abstract
Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. View Abstract
Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy. View Abstract
Mammographic appearance following accelerated partial breast irradiation by using MammoSite brachytherapy. View Abstract
Partial breast irradiation: a review of techniques and indications. View Abstract
Counterpoint: the dose rate argument--Does size matter after all? View Abstract
Rebuttal to Drs. Davidson, Hendry, and West: once burned, twice shy? View Abstract
Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. View Abstract
Radiation lobectomy-a minimally invasive treatment model for liver cancer: case report. View Abstract
Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature. View Abstract
Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. View Abstract
Intersociety Radiation Oncology Summit-SCOPE II. View Abstract
Palonosetron--a single-dose antiemetic adjunct for hepatic artery radioembolization: a feasibility study. View Abstract
Brachytherapy partial breast irradiation: analyzing effect of source configurations on dose metrics relevant to toxicity. View Abstract
Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder. View Abstract
Permanent planar iodine-125 implants: the dosimetric effect of geometric parameters for idealized source configurations. View Abstract
Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate. View Abstract
Inherent change in MammoSite applicator three-dimensional geometry over time. View Abstract
American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. View Abstract
Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors. View Abstract
Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. View Abstract
The history of the smallpox vaccine. View Abstract
The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. View Abstract
Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. View Abstract
CT computer-optimized high-dose-rate brachytherapy with surface applicator technique for scar boost radiation after breast reconstruction surgery. View Abstract
Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-up. View Abstract
Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-source. View Abstract
GAF film dosimetry of a tandem positioned beta-emitting intravascular brachytherapy source train. View Abstract
Gemcitabine-induced radiation recall. View Abstract
An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate. View Abstract
Brachytherapy for soft tissue sarcomas. View Abstract
Diversity and organization of human T cell receptor delta variable gene segments. View Abstract
Extensive junctional diversity of rearranged human T cell receptor delta genes. View Abstract